September 08, 2021

Omnicell to Host Illuminate 2021 on October 5, 6 and 7

Second annual digital event focuses on enhancing medication management to help improve clinical, operational, and business outcomes

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will host Omnicell Illuminate 2021, October 5, 6 and 7, 2021.

In its second year, Omnicell Illuminate is a first-of-its-kind digital event that brings together pharmacy, nursing, IT and healthcare leaders for educational and networking opportunities designed to support the Industry’s journey to the fully Autonomous Pharmacy.

This year’s event includes keynote and breakout sessions featuring industry luminaries and healthcare leaders discussing some of the biggest challenges in healthcare today. These interactive sessions will deliver insights, best practices, and continuing education to support improved medication management strategies for better clinical, financial, and operational outcomes.


Omnicell Illuminate 2021: the year’s biggest digital event for inspired medication management


October 5, 6 and 7

9:00 AM – 1:30 PM PDT                        

Keynote Sessions:  

Randall Lipps, Chairman, President, Chief Executive Officer, and Founder, Omnicell

George Blankenship, former executive at Tesla Motors, Apple Computer and GAP, Inc.

Scott Seidelmannn, EVP and Chief Commercial Officer, Omnicell



Free to attend and fully virtual, Omnicell Illuminate 2021 will feature CE-accredited presentations and workshops, interactive product demonstrations, and networking breakout sessions led by industry experts. Session topics will range from high-profile issues with implications across all of healthcare to those that are uniquely focused on medication management and the pharmacy care delivery model. Highlights of the three-day agenda include:

  • Innovative Mental Health Support Strategies for Healthcare Workers
  • Women in Healthcare Leadership
  • Pharmacy’s Digital Transformation post-COVID and the Path to the Fully Autonomous Pharmacy
  • How Pharmacy Can Better Use Data to Optimize Operational and Human Efficiencies
  • Optimizing 340B Programs
  • Transforming Central Pharmacy Dispensing with Automation to Achieve Business and Clinical Goals
  • Enhancing Safety and Savings with IV Robotics and Autonomous Workflow Technologies
  • Addressing the Top Ten Medication Safety Hazards with ADC Use

For more details on the full agenda and to register, visit

Forward-Looking Statements

Certain statements contained in this press release relate to future plans and objectives regarding Omnicell’s products and services.  These statements are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results and other events may differ significantly from those contemplated by forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. These risks and uncertainties include, among other things, those described in the Risk Factors section of Omnicell’s most recent annual report on Form 10-K and in the Company’s other filings with the Securities and Exchange Commission. Forward-looking statements should be considered in light of these risks and uncertainties. Investors are cautioned not to place undue reliance on forward-looking statements. All forward-looking statements contained in this press release speak only as of the date of this press release. Omnicell undertakes no obligation to update such statements, whether as a result of changed circumstances, new information, future events, or otherwise, except as required by law.

omnicell closing icon